Global Bone Grafts Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 209 pages | ID: G3F3D2EC7A3EN
Precision Business Insights (PBI)

Abstracts

Bone grafting is a surgical procedure used to fix the bones or joints. Bone grafting is replacement or repair of bones which are damaged due to trauma or fractures with the bones from other body tissue. For instance, in lumbar surgery bone from the donor site transplanted to recipient site to facilitate the fusion of vertebrae. The grafting tissue is necessary for osteoinduction, a natural bone healing process. The bone grafts are three types’ autologous, allograft, and Synthetic bone. Autologous bone harvested from patients own body, often from the iliac crest. Sallograft is cadaveric bone usually obtained from a bone bank. Synthetic bone made of hydroxyapatite or other naturally occurring, biocompatible substances. Bone grafts have a wide range of applications in sports, trauma plastic, facial, and spinal surgery.

Increase in the incidence of bone & joint disorders, technological advancements in bone grafts, development of biocompatible synthetic bone grafts, and an increase in demand for dental bone grafts are expected to drive the bone grafts market. People with diabetes are liable to suffer from joint disorders and osteoporosis and a person with obesity has 60% more susceptible to arthritis and other joint disorders. However, the high cost of surgeries and ethical issues related to bone grafting procedures expected to hinder the bone grafts market growth over forecast period. For instance, a study conducted by BioMed Central, BMC Medical Ethics found that out of 100 patients, about 20% of the patients not accepting allografts for their grafting surgery. The reasons for rejection was specific religious affiliations and people are not accepting bone from other animals for human benefit.

Bone Grafts market segmented on the basis of material, application, and end-user

Based on material, bone grafts market is segmented into

• Natural
• Autografts
• Allografts
• Synthetic
• Ceramic
• Composite
• Polymer
• Bone Morphogenetic Proteins

Based on application, bone grafts market is segmented into

• Craniomaxillofacial
• Dental
• Foot and Ankle
• Joint Reconstruction
• Long Bone Spinal fusion

Based on end-user, bone grafts market is segmented into

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

Global bone grafts market is expected to grow at steady state during forecasting period. Companies focusing on product innovations and line extensions to increase their market share. Increasing in geriatric population and growing prevalence of bone and joint disorders are the main factors boosting the worldwide bone grafts market. According to National Osteoporosis Foundation (NOF), it is expected that the number of cases with osteoporosis will exceed 61 Mn by 2020. According to National Spinal Cord Injury Centre in U.S, Researchers have assessed that in 2015, nearly 12,500 new spinal cord injuries have occurred in the year. However, larger players in bone grafts market are funding bone grafts research, collaborating and acquiring smaller players to increase their market share. For instance, In June 2016, AlloSource announced two new innovative demineralized cortical fiber allografts, the allofuse fiber boat and allofuse cortical fibers for use in a variety of spine and orthopaedic procedures. Similarly, In September 2016, RTI Surgical received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) for nanoss bioactive bone void filler in Australia. Furthermore, Venture Capitalists and Government Organisations are actively involved in funding and encouraging the research activities.

Geographically, bone grafts market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is leading the market owing to the increased number of geriatric patients, rising awareness about commercially available bone graft products among key stakeholders, high healthcare expenditure, and well-developed healthcare infrastructure in the region. Europe market is mainly driven by increased prevalence of the bone diseases and favourable regulatory environment. Developing economies such as China and India are expected to show robust growth during forecasting period due to factors such as increasing medical tourism and companies’ expansion, and growth in healthcare infrastructure in the countries. In the Middle East and Africa region, South Africa is considered one of the largest markets due to the availability of larger patient pool.

Some of the players in bone grafts market include Olympus Corporation (Olympus Biotech Corporation) (Japan), Wright Meadical Group N.V. (BioMimetic Therapeutics) (U.K.), Johnson & Johnson Services, Inc. (DePuy Synthes) (U.S.), Stryker Corporation (U.S.), Regeneration Technologies, Inc.(U.S), NuVasive, Inc. (U.S.), NovaBone Products (U.S), Medtronic.(U.S.), Zimmer, Inc. (U.S.), and LifeNet Health, Inc. (U.S.) to name a few.

In February 2016, Dentsply International, Inc. and Sirona Dental Systems, Inc. are merged to form Dentsply Sirona International.

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL BONE GRAFTS MARKET INTRODUCTION

2.1. Global Bone Grafts Market– Taxonomy
2.2. Global Bone Grafts Market–Definitions
  2.2.1. Material Type
  2.2.2. Application

3. GLOBAL BONE GRAFTS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Bone Grafts Market Dynamics – Factors Impact Analysis
3.6. Global Bone Grafts Market– Recent Market Introductions

4. GLOBAL BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL BONE GRAFTS MARKET FORECAST, BY MATERIAL TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Autografts
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Allografts
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Ceramic
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Composite
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Polymer
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Bone Morphogenetic Proteins
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis

6. GLOBAL BONE GRAFTS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Craniomaxillofacial
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Dental
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Foot and Ankle
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Joint Reconstruction
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Long Bone Spinal Fusion
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL BONE GRAFTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Dental Clinics
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL BONE GRAFTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Region, 2017 – 2023

9. NORTH AMERICA BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.1.1. Natural
      9.1.1.1.1. Autografts
      9.1.1.1.2. Allografts
    9.1.1.2. Synthetic
      9.1.1.2.1. Ceramic
      9.1.1.2.2. Composite
      9.1.1.2.3. Polymer
      9.1.1.2.4. Bone Morphogenetic Proteins
  9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Craniomaxillofacial
    9.1.2.2. Dental
    9.1.2.3. Foot and Ankle
    9.1.2.4. Joint Reconstruction
    9.1.2.5. Long Bone Spinal Fusion
  9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Hospitals
    9.1.3.2. Dental Clinics
    9.1.3.3. Ambulatory Surgical Centres
  9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    9.1.4.1. U.S.
    9.1.4.2. Canada
  9.1.5. North America Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2017 – 2023
  9.1.6. North America Bone Grafts Market Dynamics – Trends

10. EUROPE BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.1.1. Natural
      10.1.1.1.1. Autografts
      10.1.1.1.2. Allografts
    10.1.1.2. Synthetic
      10.1.1.2.1. Ceramic
      10.1.1.2.2. Composite
      10.1.1.2.3. Polymer
      10.1.1.2.4. Bone Morphogenetic Proteins
  10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Craniomaxillofacial
    10.1.2.2. Dental
    10.1.2.3. Foot and Ankle
    10.1.2.4. Joint Reconstruction
    10.1.2.5. Long Bone Spinal Fusion
  10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Hospitals
    10.1.3.2. Dental Clinics
    10.1.3.3. Ambulatory Surgical Centres
  10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Germany
    10.1.4.2. UK
    10.1.4.3. France
    10.1.4.4. Spain
    10.1.4.5. Italy
    10.1.4.6. Russia
    10.1.4.7. Poland
    10.1.4.8. Rest of Europe
  10.1.5. Europe Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2017 – 2023
  10.1.6. Europe Bone Grafts Market Dynamics – Trends

11. ASIA-PACIFIC BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.1.1. Natural
      11.1.1.1.1. Autografts
      11.1.1.1.2. Allografts
    11.1.1.2. Synthetic
      11.1.1.2.1. Ceramic
      11.1.1.2.2. Composite
      11.1.1.2.3. Polymer
      11.1.1.2.4. Bone Morphogenetic Proteins
  11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Craniomaxillofacial
    11.1.2.2. Dental
    11.1.2.3. Foot and Ankle
    11.1.2.4. Joint Reconstruction
    11.1.2.5. Long Bone Spinal Fusion
  11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Hospitals
    11.1.3.2. Dental Clinics
    11.1.3.3. Ambulatory Surgical Centres
  11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    11.1.4.1. Japan
    11.1.4.2. China
    11.1.4.3. India
    11.1.4.4. ASEAN
    11.1.4.5. Australia & New Zealand
    11.1.4.6. Rest of Asia-Pacific
  11.1.5. Asia-Pacific Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2017 – 2023
  11.1.6. Asia-Pacific Bone Grafts Market Dynamics – Trends

12. LATIN AMERICA BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.1.1. Natural
      12.1.1.1.1. Autografts
      12.1.1.1.2. Allografts
    12.1.1.2. Synthetic
      12.1.1.2.1. Ceramic
      12.1.1.2.2. Composite
      12.1.1.2.3. Polymer
      12.1.1.2.4. Bone Morphogenetic Proteins
  12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Craniomaxillofacial
    12.1.2.2. Dental
    12.1.2.3. Foot and Ankle
    12.1.2.4. Joint Reconstruction
    12.1.2.5. Long Bone Spinal Fusion
  12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Hospitals
    12.1.3.2. Dental Clinics
    12.1.3.3. Ambulatory Surgical Centres
  12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Brazil
    12.1.4.2. Mexico
    12.1.4.3. Argentina
    12.1.4.4. Venezuela
    12.1.4.5. Rest of Latin America
  12.1.5. Latin America Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, End User, and Country, 2017 – 2023
  12.1.6. Latin America Bone Grafts Market Dynamics – Trends

13. MIDDLE EAST & AFRICA BONE GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Material Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.1.1. Natural
      13.1.1.1.1. Autografts
      13.1.1.1.2. Allografts
    13.1.1.2. Synthetic
      13.1.1.2.1. Ceramic
      13.1.1.2.2. Composite
      13.1.1.2.3. Polymer
      13.1.1.2.4. Bone Morphogenetic Proteins
  13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Craniomaxillofacial
    13.1.2.2. Dental
    13.1.2.3. Foot and Ankle
    13.1.2.4. Joint Reconstruction
    13.1.2.5. Long Bone Spinal Fusion
  13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Hospitals
    13.1.3.2. Dental Clinics
    13.1.3.3. Ambulatory Surgical Centres
  13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.4.1. Gulf Cooperation Council (GCC) Countries
    13.1.4.2. Israel
    13.1.4.3. South Africa
    13.1.4.4. Rest of MEA
  13.1.5. MEA Bone Grafts Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2017 – 2023
  13.1.6. MEA Bone Grafts Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Olympus Corporation (Olympus Biotech Corporation) (Japan)
  14.2.2. Wright Meadical Group N.V. (BioMimetic Therapeutics) (U.K.)
  14.2.3. Johnson & Johnson Services, Inc. (DePuy Synthes) (U.S.)
  14.2.4. Stryker Corporation (U.S.)
  14.2.5. Regeneration Technologies, Inc.(U.S)
  14.2.6. NuVasive, Inc. (U.S.)
  14.2.7. NovaBone Products (U.S)
  14.2.8. Medtronic.(U.S.)
  14.2.9. Zimmer, Inc. (U.S.)
  14.2.10. LifeNet Health, Inc. (U.S.)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS